{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:56:35Z","timestamp":1784591795189,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>HIV-monoinfected patients may be at risk for significant liver fibrosis, but its prevalence and determinants in these patients are unknown. Since HIV-monoinfected patients do not routinely undergo liver biopsy, we evaluated the prevalence and risk factors of significant hepatic fibrosis in this group using the aspartate aminotransferase (AST)-to-platelet ratio index (APRI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a cross-sectional study among HIV-infected patients negative for hepatitis B surface antigen and hepatitis C antibody in the Penn Center for AIDS Research Adult\/Adolescent Database. Clinical and laboratory data were collected from the database at enrollment. Hypothesized determinants of significant fibrosis were modifiable risk factors associated with liver disease progression, hepatic fibrosis, or hepatotoxicity, including immune dysfunction (i.e., CD4 T lymphocyte count &lt;200 cells\/mm<jats:sup>3<\/jats:sup>, HIV viremia), diseases associated with hepatic steatosis (e.g., obesity, diabetes mellitus), and use of antiretroviral therapy. The primary outcome was an APRI score &gt;1.5, which suggests significant hepatic fibrosis. Multivariable logistic regression identified independent risk factors for significant fibrosis by APRI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 432 HIV-monoinfected patients enrolled in the CFAR Database between November 1999 and May 2008, significant fibrosis by APRI was identified in 36 (8.3%; 95% CI, 5.9 - 11.4%) patients. After controlling for all other hypothesized risk factors as well as active alcohol use and site, detectable HIV viremia (adjusted OR, 2.56; 95% CI, 1.02 - 8.87) and diabetes mellitus (adjusted OR, 3.15; 95% CI, 1.12 - 10.10) remained associated with significant fibrosis by APRI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Significant fibrosis by APRI score was found in 8% of HIV-monoinfected patients. Detectable HIV viremia and diabetes mellitus were associated with significant fibrosis. Future studies should explore mechanisms for fibrosis in HIV-monoinfected patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-10-116","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T06:13:52Z","timestamp":1273817632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients"],"prefix":"10.1186","volume":"10","author":[{"given":"Michelle","family":"DallaPiazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerianna K","family":"Amorosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Localio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R","family":"Kostman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Vincent","family":"Lo Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"issue":"15","key":"1096_CR1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, et al: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166 (15): 1632-1641. 10.1001\/archinte.166.15.1632.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1096_CR2","doi-asserted-by":"publisher","first-page":"e4517","DOI":"10.1371\/journal.pone.0004517","volume":"4","author":"EE Moodie","year":"2009","unstructured":"Moodie EE, Pant Pai N, Klein MB: Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV\/hepatitis C co-infected cohorts. PLoS One. 2009, 4 (2): e4517-10.1371\/journal.pone.0004517.","journal-title":"PLoS One"},{"issue":"2","key":"1096_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.qai.0000221683.44940.62","volume":"42","author":"I Maida","year":"2006","unstructured":"Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, Rivas P, Barreiro P, Mura MS, Babudieri S, et al: Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr. 2006, 42 (2): 177-182. 10.1097\/01.qai.0000221683.44940.62.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"1096_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","volume":"19","author":"MS Sulkowski","year":"2005","unstructured":"Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL: Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005, 19 (6): 585-592. 10.1097\/01.aids.0000163935.99401.25.","journal-title":"AIDS"},{"issue":"12","key":"1096_CR5","first-page":"2563","volume":"91","author":"JK Rockstroh","year":"1996","unstructured":"Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U, Bierhoff E, Fischer HP, Oldenburg J, Brackmann HH, et al: Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol. 1996, 91 (12): 2563-2568.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1096_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2893.2007.00903.x","volume":"15","author":"C Castellares","year":"2008","unstructured":"Castellares C, Barreiro P, Martin-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, Garcia-Gasco P, Garcia-Samaniego J, Soriano V: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat. 2008, 15 (3): 165-172.","journal-title":"J Viral Hepat"},{"key":"1096_CR7","unstructured":"Sulkowski MS, Mehta S, Montes de Occa R, Moore RD, Thomas DL: Estimated prevalence of significant liver disease among 4,052 HIV-infected adults with and without chronic hepatitis B and C. 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA. February 5-8, 2006 [Abstract 842]."},{"issue":"6","key":"1096_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1468-1293.2005.00330.x","volume":"6","author":"H Al-Mohri","year":"2005","unstructured":"Al-Mohri H, Cooper C, Murphy T, Klein MB: Validation of a simple model for predicting liver fibrosis in HIV\/hepatitis C virus-coinfected patients. HIV Med. 2005, 6 (6): 375-378. 10.1111\/j.1468-1293.2005.00330.x.","journal-title":"HIV Med"},{"issue":"1","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2005.02.025","volume":"43","author":"TB Kelleher","year":"2005","unstructured":"Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH: Prediction of hepatic fibrosis in HIV\/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol. 2005, 43 (1): 78-84. 10.1016\/j.jhep.2005.02.025.","journal-title":"J Hepatol"},{"issue":"5","key":"1096_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.qai.0000184856.31695.bf","volume":"40","author":"D Nunes","year":"2005","unstructured":"Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, et al: HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005, 40 (5): 538-544. 10.1097\/01.qai.0000184856.31695.bf.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1096_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.21757","volume":"46","author":"JA Pineda","year":"2007","unstructured":"Pineda JA, Garcia-Garcia JA, Aguilar-Guisado M, Rios-Villegas MJ, Ruiz-Morales J, Rivero A, del Valle J, Luque R, Rodriguez-Bano J, Gonzalez-Serrano M, et al: Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology. 2007, 46 (3): 622-630. 10.1002\/hep.21757.","journal-title":"Hepatology"},{"issue":"3","key":"1096_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0b013e318050d864","volume":"45","author":"P Loulergue","year":"2007","unstructured":"Loulergue P, Callard P, Bonnard P, Pialoux G: Hepatic steatosis as an emerging cause of cirrhosis in HIV-infected patients. J Acquir Immune Defic Syndr. 2007, 45 (3): 365-","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1096_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1468-1293.2008.00651.x","volume":"10","author":"P Ryan","year":"2009","unstructured":"Ryan P, Blanco F, Garcia-Gasco P, Garcia-Merchan J, Vispo E, Barreiro P, Labarga P, Gonzalez-Lahoz J, Soriano V: Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients. HIV Med. 2009, 10 (1): 53-59. 10.1111\/j.1468-1293.2008.00651.x.","journal-title":"HIV Med"},{"issue":"6","key":"1096_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","volume":"125","author":"JM Hui","year":"2003","unstructured":"Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J: Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology. 2003, 125 (6): 1695-1704. 10.1053\/j.gastro.2003.08.032.","journal-title":"Gastroenterology"},{"issue":"5","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/00002030-200403260-00007","volume":"18","author":"J Macias","year":"2004","unstructured":"Macias J, Castellano V, Merchante N, Palacios RB, Mira JA, Saez C, Garcia-Garcia JA, Lozano F, Gomez-Mateos JM, Pineda JA: Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS. 2004, 18 (5): 767-774. 10.1097\/00002030-200403260-00007.","journal-title":"AIDS"},{"issue":"1","key":"1096_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0b013e3282f0e2fd","volume":"22","author":"V Soriano","year":"2008","unstructured":"Soriano V, Puoti M, Garcia-Gasco P, Rockstroh JK, Benhamou Y, Barreiro P, McGovern B: Antiretroviral drugs and liver injury. AIDS. 2008, 22 (1): 1-13. 10.1097\/QAD.0b013e3282f0e2fd.","journal-title":"AIDS"},{"issue":"3","key":"1096_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/QAI.0b013e31802ea499","volume":"44","author":"V Lo Re","year":"2007","unstructured":"Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, et al: Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr. 2007, 44 (3): 315-320. 10.1097\/QAI.0b013e31802ea499.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"1096_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38 (2): 518-526. 10.1053\/jhep.2003.50346.","journal-title":"Hepatology"},{"issue":"5","key":"1096_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jama.300.5.555","volume":"300","author":"SM Hammer","year":"2008","unstructured":"Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, et al: Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008, 300 (5): 555-570. 10.1001\/jama.300.5.555.","journal-title":"JAMA"},{"key":"1096_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, New York: Chapman and Hall"},{"issue":"10","key":"1096_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1365-2036.2007.03309.x","volume":"25","author":"O Lo Iacono","year":"2007","unstructured":"Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S, Di Marco V, Rodolico V, Amato M, Ferraro D, Giordano C, et al: The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2007, 25 (10): 1181-1191. 10.1111\/j.1365-2036.2007.03309.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4 Pt 1","key":"1096_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.28055","volume":"34","author":"V Paradis","year":"2001","unstructured":"Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, Conti M, Huet S, Ba N, Buffet C, et al: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001, 34 (4 Pt 1): 738-744. 10.1053\/jhep.2001.28055.","journal-title":"Hepatology"},{"issue":"8","key":"1096_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/MCG.0b013e31818be17c","volume":"43","author":"SX Hu","year":"2009","unstructured":"Hu SX, Kyulo NL, Xia VW, Hillebrand DJ, Hu KQ: Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients. J Clin Gastroenterol. 2009, 43 (8): 758-764. 10.1097\/MCG.0b013e31818be17c.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1572-0241.2008.01813.x","volume":"103","author":"S Petta","year":"2008","unstructured":"Petta S, Camma C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, et al: Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol. 2008, 103 (5): 1136-1144. 10.1111\/j.1572-0241.2008.01813.x.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1096_CR25","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1111\/j.1572-0241.2006.00835.x","volume":"101","author":"N Taura","year":"2006","unstructured":"Taura N, Ichikawa T, Hamasaki K, Nakao K, Nishimura D, Goto T, Fukuta M, Kawashimo H, Fujimoto M, Kusumoto K, et al: Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol. 2006, 101 (12): 2752-2759. 10.1111\/j.1572-0241.2006.00835.x.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1096_CR26","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Keach JC, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999, 30 (6): 1356-1362. 10.1002\/hep.510300604.","journal-title":"Hepatology"},{"issue":"3","key":"1096_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10620-007-9942-x","volume":"53","author":"K Jaskiewicz","year":"2008","unstructured":"Jaskiewicz K, Rzepko R, Sledzinski Z: Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. Dig Dis Sci. 2008, 53 (3): 785-788. 10.1007\/s10620-007-9942-x.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1096_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","volume":"42","author":"LA Adams","year":"2005","unstructured":"Adams LA, Sanderson S, Lindor KD, Angulo P: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005, 42 (1): 132-138. 10.1016\/j.jhep.2004.09.012.","journal-title":"J Hepatol"},{"issue":"22","key":"1096_CR29","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","volume":"355","author":"WM El-Sadr","year":"2006","unstructured":"El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, et al: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006, 355 (22): 2283-2296. 10.1056\/NEJMoa062360.","journal-title":"N Engl J Med"},{"key":"1096_CR30","unstructured":"Tuyama A, Hong F, Mosoian A, Chen P, Fiel I, Schecter A, Klotman M, Bansal M: HIV entry and replication in stellate cells promotes cellular activation and fibrogenesis: Implications for hepatic fibrosis in HIV\/HCV co-infection. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA. February 3-6, 2008 [Abstract 57]."},{"issue":"4","key":"1096_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00126334-200104010-00008","volume":"26","author":"M Bonacini","year":"2001","unstructured":"Bonacini M, Lin HJ, Hollinger FB: Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr. 2001, 26 (4): 340-344.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"1096_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JCM.38.2.575-577.2000","volume":"38","author":"CL Thio","year":"2000","unstructured":"Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL: Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000, 38 (2): 575-577.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1096_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gut.2005.065904","volume":"55","author":"J Macias","year":"2006","unstructured":"Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruiz-Morales J, Lomas-Cabeza JM, Garcia-Garcia JA, et al: Prediction of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut. 2006, 55 (3): 409-414. 10.1136\/gut.2005.065904.","journal-title":"Gut"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T19:46:40Z","timestamp":1711482400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-116","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]},"assertion":[{"value":"29 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"116"}}